Fig. 1From: HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjectsHLA-B*57:01 prevalence by state within the subject population at the screening visitBack to article page